Molecular Devices Corp. has released SoftMax Pro 5 GxP, data-acquisition and -analysis software that includes CFR Part 11 compliance features for the pharmaceutical and biotechnology industries. The software was developed specifically for customers who are required to comply with multiple regulatory requirements. It contains networked-linked user-management tools that allow companies to host securely and manage authorized users worldwide. It also includes complete validation tools to reduce cost and validation times.

“We solicited input from researchers from more than 50 leading pharmaceutical and biotechnology companies to address research, validation and IT requirements, and their feedback is evident in the new software capabilities,” says Jan Hughes, Molecular Devices vice president for marketing.

The SoftMax Pro 5 GxP suite includes SoftMax Pro 5, which is designed for research and academic laboratories. Molecular Devices Corp. is a provider of high-performance bioanalytical measurement systems for drug discovery and other life sciences research.

For more information, visit www.moleculardevices.com.

 …